American International Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-500
Closed -$22K 5193
2015
Q3
$22K Sell
500
-175
-26% -$7.38K ﹤0.01% 4264
2015
Q2
$28.5K Buy
+675
New +$28.5K ﹤0.01% 4262
2014
Q4
Sell
-1,000
Closed -$35K 5126
2014
Q3
$35K Hold
1,000
﹤0.01% 4125
2014
Q2
$32.9K Sell
1,000
-5,485
-85% -$188K ﹤0.01% 4123
2014
Q1
$239K Buy
6,485
+1,029
+19% +$37.8K ﹤0.01% 2685
2013
Q4
$209K Buy
5,456
+5,356
+5,356% +$169K ﹤0.01% 2743
2013
Q3
$2.74K Hold
100
﹤0.01% 4483
2013
Q2
$2.1K Buy
+100
New +$1.95K ﹤0.01% 4430

Other funds holding WX

American International Group's WX Position: Q4 2015 in Review

American International Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 500 shares — an estimated $22K sold.

American International Group first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $239K in Q1 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • American International Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • American International Group sold 500 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $22K.
  • American International Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
  • American International Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $239K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on American International Group's 13F filing for Q4 2015, filed 11 Feb 2016.